 hepatocellular carcinoma italian patient cirrhosi background and method patient cirrhosi liver risk hepatocellular carcinoma magnitud risk natur histori diseas possibl curabl tumor patient western world unknown question italian patient well-compens cirrhosi viral origin percent serum alpha-fetoprotein assay real-tim ultrasonographi month result hepatocellular carcinoma patient percent base line patient percent patient free tumor base line follow-up period month rang cumul hazard develop hepatocellular carcinoma follow-up patient serum alpha-fetoprotein level tumor level fluctuat level normal level patient oper tumor proport oper tumor follow-up proport enrol surviv year patient surgeri percent tumor-recurr rate percent outcom differ patient surgeri conclus west asia patient cirrhosi liver substanti risk hepatocellular carcinoma yearli incid rate percent program rate detect curabl tumor